Advertisement
Advertisement
U.S. markets close in 1 hour 8 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Quest Diagnostics Incorporated (DGX)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
137.81+0.64 (+0.47%)
As of 02:52PM EST. Market open.
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Double Moving Average Crossover

Double Moving Average Crossover

Previous Close137.17
Open138.34
Bid137.78 x 1200
Ask137.88 x 1000
Day's Range137.30 - 139.25
52 Week Range113.36 - 174.16
Volume551,846
Avg. Volume1,189,095
Market Cap16.906B
Beta (5Y Monthly)1.02
PE Ratio (TTM)8.29
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield2.48 (1.81%)
Ex-Dividend DateJan 18, 2022
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Undervalued
19% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for DGX

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Quest Diagnostics Incorporated
    Analyst Report: Quest Diagnostics IncorporatedQuest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the U.S. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk assessment services, and information technology solutions.
    Rating
    Fair Value
    Economic Moat
    11 days agoMorningstar
View more
All
News
Press Releases
Advertisement
Advertisement